The aim of this study was to assess computed-tomography histogram analysis (CTHA) as prognostic and predictive factor in platinum-refractory non-small cell lung carcinoma (NSCLC) treated with immune checkpoint inhibitor Nivolumab
Background The early response to treatment with immune-checkpoint inhibitors is difficult to evaluat...
International audienceIntroduction: To evaluate the value of image-based texture analysis for predic...
Metastatic non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (IC...
Purpose: The aim of this study was to assess computed-tomography histogram analysis (CTHA) as progno...
Background: Attempts to isolate reliable predictive biomarkers have been unsuccessful for the use of...
Background: Immune-checkpoint inhibitors have radically changed the treatment landscape of Non-Small...
Immune checkpoint blockade is an emerging anticancer strategy, and Nivolumab is a human mAb to PD-1 ...
An emerging clinical need is represented by identifying reliable biomarkers able to dis-criminate be...
Abstract Background The advent of immune checkpoint inhibitors (ICIs) has considerably expanded the ...
OBJECTIVES: Assess computed tomography texture analysis of patients likely to benefit from nivolumab...
BackgroundImmune checkpoint inhibitors (ICIs) plus chemotherapy improved the prognosis of patients w...
BackgroundImmune checkpoint inhibitors (ICIs) plus chemotherapy improved the prognosis of patients w...
Lung cancer remains the leading cause of cancer-related death, and it is usually diagnosed in advanc...
ObjectivesWe aimed to examine clinical data and baseline blood test results as potential predictive ...
Background The early response to treatment with immune-checkpoint inhibitors is difficult to evaluat...
International audienceIntroduction: To evaluate the value of image-based texture analysis for predic...
Metastatic non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (IC...
Purpose: The aim of this study was to assess computed-tomography histogram analysis (CTHA) as progno...
Background: Attempts to isolate reliable predictive biomarkers have been unsuccessful for the use of...
Background: Immune-checkpoint inhibitors have radically changed the treatment landscape of Non-Small...
Immune checkpoint blockade is an emerging anticancer strategy, and Nivolumab is a human mAb to PD-1 ...
An emerging clinical need is represented by identifying reliable biomarkers able to dis-criminate be...
Abstract Background The advent of immune checkpoint inhibitors (ICIs) has considerably expanded the ...
OBJECTIVES: Assess computed tomography texture analysis of patients likely to benefit from nivolumab...
BackgroundImmune checkpoint inhibitors (ICIs) plus chemotherapy improved the prognosis of patients w...
BackgroundImmune checkpoint inhibitors (ICIs) plus chemotherapy improved the prognosis of patients w...
Lung cancer remains the leading cause of cancer-related death, and it is usually diagnosed in advanc...
ObjectivesWe aimed to examine clinical data and baseline blood test results as potential predictive ...
Background The early response to treatment with immune-checkpoint inhibitors is difficult to evaluat...
International audienceIntroduction: To evaluate the value of image-based texture analysis for predic...
Metastatic non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (IC...